Publications by authors named "Gaurav Goyal"

Claim this Profile
C
Cardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes.
Reema K Tawfiq, Grant M Spears, Jason R Young, Madeline K Mahowald, W Oliver Tobin, Gaurav Goyal

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasms.
Aishwarya Ravindran, Liuyan Jiang, Gordon J Ruan, Surendra Dasari, Jithma P Abeykoon, Gaurav Goyal

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The xanthogranuloma family of histiocytic neoplasms in the molecular era: Erdheim-Chester disease and beyond.
Gaurav Goyal, Ronald S Go

Hematology Am Soc Hematol Educ Program· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to the Review Series. Looking back and to the future: the Histiocyte Society blueprint for research in histiocytic disorders.
Gaurav Goyal, Vasanta Nanduri

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration.
Oshrat Hershkovitz-Rokah, Jithma P Abeykoon, Aishwarya Ravindran, Gaurav Goyal

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indeterminate Dendritic Cell Histiocytosis Harboring ETV3::NCOA2 Translocation with Complete Metabolic Response to MEK Inhibition.
Vyshnavi Rallapalle, Jennifer Toral-Orduno, Brinda Shukla, Lauren Graham, Lauren Kole, Gaurav Goyal

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Rosai-Dorfman disease with near-complete response to the MEK inhibitor cobimetinib.
Vyshnavi Rallapalle, Lauren Kole, Peter Pavlidakey, Pradeep Bhambhvani, Shuko Harada, Gaurav Goyal

JAAD Case Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in patients with lymphoma.
Adi Zoref-Lorenz, Jun Murakami, Ronit Gurion, Swaminathan P Iyer, Uri Abadi, Gaurav Goyal

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptoms, unmet needs, and quality of life in Erdheim-Chester disease: a longitudinal registry-based analysis.
Priya H Marathe, Anne S Reiner, Dana Bossert, Allison M Sigler, Deanna Fournier, Gaurav Goyal

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling is critical to guide MEK inhibitor use in Erdheim-Chester disease.
Gaurav Goyal, Aldo A Acosta-Medina, Ronald S Go, Jithma P Abeykoon,

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease.
Michelangelo Tesi, Francesco Pegoraro, Francesco Peyronel, Jean-François Emile, Francesco Catamerò, Gaurav Goyal

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Chronic Health Conditions Among People With HIV and Common Non-AIDS-Defining Cancers.
Gaurav Goyal, Ene M Enogela, Greer A Burkholder, Mari M Kitahata, Heidi M Crane

J Natl Compr Canc Netw· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Perspectives on Mesenchymal Dendritic Cell Neoplasms of Lymphoid Tissue: Insights into Ontogeny, Updates on Classification, and Clinicopathologic Characteristics.
Neha Seth, Jithma P Abeykoon, Gaurav Goyal, Ronald S Go, Steven Tessier

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder.
Polyzois Makras, Dana Erickson, Caroline J Davidge-Pitts, Eli L Diamond, Carl E Allen, Gaurav Goyal

J Clin Endocrinol Metab· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes with single-agent BRAF inhibitor therapy in Erdheim-Chester disease.
Gaurav Goyal, Anne S Reiner, Dana Bossert, Allison M Sigler, Mario E Lacouture

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants.
Aldo A Acosta-Medina, Jithma P Abeykoon, Saurabh Zanwar, Gordon J Ruan, Karen L Rech, Gaurav Goyal

Leukemia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall and Cause-Specific Mortality Among Patients With Cutaneous T-Cell Lymphoma in the United States.
Lauren Shea, Mayur Narkhede, Karthik Chamarti, Tina Gao, Amitkumar Mehta, Gaurav Goyal

EJHaem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiety and depression in patients with histiocytic neoplasms and their associated clinical features.
Anne S Reiner, Yesne Alici, Denise D Correa, Dana Bossert, Allison M Sigler, Gaurav Goyal

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma.
Kathryn Lurain, Ramya Ramaswami, Irene Ekwede, Vanessa Eulo, Gaurav Goyal

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosai-Dorfman disease disguised as BRAF V600E-positive histiocytosis - a diagnostic pitfall.
Aishwarya Ravindran, Gaurav Goyal, Diana Morlote, Alexander C Mackinnon

Blood Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations.
Katherine E R Smith, Aldo A Acosta-Medina, Surendra Dasari, Wasantha Ranatunga, Karen L Rech, Gaurav Goyal

JCO Precis Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver involvement with Langerhans cell histiocytosis in adults.
Long Chang, Hua-Cong Cai, Min Lang, He Lin, Ya-Ping Luo, Gaurav Goyal

Oncologist· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
Alex F Herrera, Michael LeBlanc, Sharon M Castellino, Hongli Li, Sarah C Rutherford, Gaurav Goyal

N Engl J Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms.
Samantha A Banks, Paul Decker, Eoin P Flanagan, Anastasia Zekeridou, Ronald S Go, Gaurav Goyal

Blood Cancer J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of first-line tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and network meta-analysis.
Jing-Jing Zhang, Yu-Lan Qian, Zi-Yang Wu, Yue Li, Ying-Jie Guan, Gaurav Goyal

Transl Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis